Join
Live feed
·
INSIDERFilingvia Quantisnow
Avalo Therapeutics Inc. logo

Chief Financial Officer Sullivan Christopher Ryan covered exercise/tax liability with 155 shares, decreasing direct ownership by 0.89% to 17,338 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AVTX· Avalo Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVTX (Avalo Therapeutics Inc.) and more on Quantisnow.